News

Partnership aims to develop custom cell-based assay solutions to support biopharmaceutical research and development.

Understanding of the physical root of depression has been advanced, thanks to new research.

For patients with chronic back pain, "open" treatment with placebo—informing patients that they are taking an inactive pill, and why it might be helpful—leads to reductions in pain and disability, reports a study in Pain, the official publication of the International Association for the Study of Pain (IASP).

Dr Matthew Hurles, co-founder of Congenica, will explain how the bottlenecks of consistency and data sharing are being addressed in a presentation at ASHG.

Prescription doses of folinic acid, which is a reduced form of a B vitamin known as folate, could help improve the language and communication skills of children with autism spectrum disorder (ASD). These are the preliminary findings from a placebo-controlled trial in which children were randomized to receive either high-dose folinic acid or a placebo, says lead author Richard Frye of Arkansas Children's Research Institute in the US.

Brain cells that provide structural support also influence feeding behavior, study shows.

By utilizing orthogonal techniques, researchers can maximize the secure application of all analytical results generated.

Biocompatible fibers could use light to stimulate cells or sense signs of disease.

Scientists show for the first time how bacterial superantigen toxins work, and how short peptides can block them and save lives.

Researchers at NIH have suggested that the multiple alpha tryptase gene copies might underlie health issues that affect a substantial number of people.